Risk factors identification of COVID-19 patients with chronic obstructive pulmonary disease: A retrospective study in Punjab-Pakistan
- PMID: 37647450
- PMCID: PMC10461420
- DOI: 10.1002/iid3.981
Risk factors identification of COVID-19 patients with chronic obstructive pulmonary disease: A retrospective study in Punjab-Pakistan
Abstract
Background: Accessibility to the immense collection of studies on noncommunicable diseases related to coronavirus disease of 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an immediate focus of researchers. However, there is a scarcity of information about chronic obstructed pulmonary disease (COPD), which is associated with a high rate of infection in COVID-19 patients. Moreover, by combining the effects of the SARS-CoV-2 on COPD patients, we may be able to overcome formidable obstacles factors, and diagnosis influencers.
Materials and methods: A retrospective study of 280 patients was conducted at DHQ Hospital Muzaffargarh in Punjab, Pakistan. Negative binomial regression describes the risk of fixed successive variables. The association is described by the Cox proportional hazard model and the model coefficient is determined through log-likelihood observation. Patients with COPD had their survival and mortality plotted on Kaplan-Meier curves.
Results: The increased risk of death in COPD patients was due to the effects of variables such as cough, lower respiratory tract infection (LRTI), tuberculosis (TB), and body-aches being 1.369, 0.693, 0.170, and 0.217 times higher at (95% confidence interval [CI]: 0.747-1.992), (95% CI: 0.231-1.156), (95% CI: 0.008-0.332), and (95% CI: -0.07 to 0.440) while it decreased 0.396 in normal condition.
Conclusion: We found that the symptoms of COPD (cough, LRTI, TB, and bodyaches) are statistically significant in patients who were most infected by SARS-CoV-2.
Keywords: COPD; COVID-19; Cox proportional hazard model and negative binomial distribution; SARS-CoV-2.
© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis.Ann Med. 2023 Dec;55(1):285-291. doi: 10.1080/07853890.2022.2160491. Ann Med. 2023. PMID: 36594409 Free PMC article.
-
The Complex Relationship Between Chronic Obstructive Pulmonary Disease With Cardiovascular Disease and Their Interactions With COVID-19 Vaccination: A Retrospective Study.Immun Inflamm Dis. 2024 Nov;12(11):e70068. doi: 10.1002/iid3.70068. Immun Inflamm Dis. 2024. PMID: 39555721 Free PMC article.
-
Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1695-1703. doi: 10.11817/j.issn.1672-7347.2022.210596. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36748380 Free PMC article. Chinese, English.
-
COVID-19 Susceptibility in chronic obstructive pulmonary disease.Eur J Clin Invest. 2020 Oct;50(10):e13382. doi: 10.1111/eci.13382. Epub 2020 Sep 2. Eur J Clin Invest. 2020. PMID: 32780415 Free PMC article. Review.
-
Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.BMC Infect Dis. 2021 Feb 22;21(1):200. doi: 10.1186/s12879-021-05915-0. BMC Infect Dis. 2021. PMID: 33618678 Free PMC article.
Cited by
-
Inhaled corticosteroids and Stenotrophomonas maltophilia in outpatients with chronic obstructive pulmonary disease: a retrospective cohort study.BMJ Open Respir Res. 2024 Mar 9;11(1):e001929. doi: 10.1136/bmjresp-2023-001929. BMJ Open Respir Res. 2024. PMID: 38460975 Free PMC article.
-
Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study.BMJ Open Respir Res. 2024 Dec 12;11(1):e002366. doi: 10.1136/bmjresp-2024-002366. BMJ Open Respir Res. 2024. PMID: 39668106 Free PMC article.
-
Chronic Obstructive Pulmonary Disease Patients With Community-Acquired Pneumonia on Inhaled Corticosteroid Therapy: A Comprehensive Analysis of Risk Factors, Disease Burden, and Prevention Strategies.Health Sci Rep. 2025 Jan 26;8(1):e70395. doi: 10.1002/hsr2.70395. eCollection 2025 Jan. Health Sci Rep. 2025. PMID: 39872908 Free PMC article.
-
Socio-demographic environmental and clinical factors influencing asthma control in community pharmacies of Lahore Pakistan.Sci Rep. 2025 Mar 27;15(1):10587. doi: 10.1038/s41598-025-95373-4. Sci Rep. 2025. PMID: 40148570 Free PMC article.
-
Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review.Immun Inflamm Dis. 2024 Apr;12(4):e1259. doi: 10.1002/iid3.1259. Immun Inflamm Dis. 2024. PMID: 38661301 Free PMC article.
References
-
- Duchene S, Featherstone L, Freiesleben de Blasio B, Holmes EC, Bohlin J, Pettersson JHO. The impact of public health interventions in the Nordic countries during the first year of SARS‐CoV‐2 transmission and evolution. Euro Surveill. 2021;26(44):2001996. 10.2807/1560-7917.ES.2021.26.44.2001996 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous